¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"OT"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
5
ÆäÀÌÁö:
19
ÄÚµå
¿µ¹®
ÇѱÛ
T46.9
Other and unspecified agents primarily affecting the cardiovascular system
±âŸ ¹× »ó¼¼ºÒ¸íÀÇ ÀÏÂ÷ÀûÀ¸·Î ½ÉÀåÇ÷°ü°èÅë¿¡ ¿µÇâÀ» ÁÖ´Â ¾à¹°
Y49.2
Other and unspecified antidepressants
±âŸ ¹× »ó¼¼ºÒ¸íÀÇ Ç׿ì¿ïÁ¦
T43.2
Other and unspecified antidepressants
±âŸ ¹× »ó¼¼ºÒ¸íÀÇ Ç׿ì¿ïÁ¦
Y46.6
Other and unspecified antiepileptics
±âŸ ¹× »ó¼¼ºÒ¸íÀÇ Ç×°£ÁúÁ¦
T43.5
Other and unspecified antipsychotics and neuroleptics
±âŸ ¹× »ó¼¼ºÒ¸íÀÇ Ç×Á¤½Åº´¾à ¹× ½Å°æÀÌ¿ÏÁ¦
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
19
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½